Britain will give alternative vaccine of AstraZeneca for people under 30 years age

The country's Medicines and Healthcare Products Regulatory Agency (MHRA) said regular monitoring has concluded that there is a high potential for rare blood clots due to the AstraZeneca vaccine. So, people should be vaccinated by Pfizer and Moderna.

The British drug regulator said on Wednesday that people under the age of 30 in the country would be given another vaccine in exchange for the AstraZeneca Oxford vaccine. The move came as reports of rare blood clots including the AstraZeneca vaccine.

The government’s Joint Committee on Vaccination and Immunization has said that adults aged between 18 and 29, who do not have health risks or risks from Covid-19, should be given alternative vaccines, where available, where UK vaccination exports are increasing.

Prime Minister Boris Johnson said people should “continue to have full confidence” in AstraZeneca and other vaccines while Labour leader Sir Keir Starmer said the vaccine was “safe, effective and saving thousands of lives” telling people need to trust “our doctors and scientists”.

The Medicines and Healthcare Products Regulatory Agency (MHRA) on Wednesday said regular monitoring had concluded that there was a high risk of developing unusual blood clots due to the AstraZeneca vaccine. So, people of the age group should be vaccinated by Pfizer and Moderna. MHRA chief executive Dr. June Raine, however, said the benefits of the AstraZeneca vaccine were greater for many people than the risks.

According to the MHRA, out of every 10 lakh vaccinated people, only 4 people are at risk of developing abnormal blood clots. The decision was announced shortly after the European Union's drug director announced that it had discovered a possible link between the AstraZeneca vaccine and the unusual blood.